ER-positive (estrogen receptor-positive) breast cancer is one of the most common forms of breast cancer. In this type of cancer, tumor cells contain receptors that respond to the hormone estrogen. When estrogen attaches to these receptors, it can stimulate cancer cells to grow and multiply.
Because the cancer relies on estrogen, treatment often focuses on blocking the hormone’s effects or reducing estrogen levels in the body. This approach can help slow or stop tumor growth and lower the risk of recurrence.
What Is ER-Positive Breast Cancer?
Breast cancer cells are tested to determine whether they carry receptors for hormones such as estrogen and progesterone. Tumors that contain estrogen receptors are classified as ER-positive.
If cancer cells have estrogen receptors, progesterone receptors, or both, the disease is considered hormone receptor-positive breast cancer. These cancers account for the majority of breast cancer diagnoses and often respond well to hormone-targeted treatments.
Risk Factors
Several factors may increase the likelihood of developing ER-positive breast cancer, including:
- Being female
- Increasing age
- Long-term exposure to estrogen and progesterone
- Early onset of menstruation
- Late menopause
- Having no children
- Use of certain hormone-based therapies
- Excessive alcohol consumption
- Obesity after menopause
- Limited physical activity
Men can also develop ER-positive breast cancer, although it is much less common.
Symptoms
Symptoms of ER-positive breast cancer are similar to those of other breast cancer types and may include:
- A lump or thickened area in the breast
- Changes in breast shape or size
- Nipple discharge
- Breast or nipple pain
- Skin dimpling or irritation
- Redness or thickening of breast skin
- Changes in the appearance of the nipple
Not all breast cancers cause noticeable symptoms in the early stages.
How ER-Positive Breast Cancer Is Diagnosed
Diagnosis typically begins with imaging tests such as:
- Mammography
- Breast ultrasound
- Magnetic resonance imaging (MRI)
If a suspicious area is found, a biopsy is performed. During the biopsy, a sample of tissue is removed and analyzed in a laboratory. Specialists determine whether cancer is present and whether hormone receptors are driving tumor growth.
The results help guide treatment decisions.
Treatment Options
Hormone Therapy
Hormone therapy is the primary treatment for ER-positive breast cancer. These medications either reduce estrogen levels or prevent estrogen from attaching to cancer cells.
Ovarian Suppression Therapy
For premenopausal women, medications may be used to temporarily stop the ovaries from producing estrogen. This reduces the hormone available to fuel cancer growth.
Common side effects include:
- Hot flashes
- Mood changes
- Vaginal dryness
Aromatase Inhibitors
These drugs lower estrogen production in postmenopausal women by blocking an enzyme involved in estrogen formation.
Potential side effects include:
- Joint pain
- Muscle aches
- Increased risk of osteoporosis
Selective Estrogen Receptor Modulators (SERMs)
SERMs block estrogen receptors on breast cancer cells, preventing estrogen from stimulating tumor growth.
Possible side effects include:
- Hot flashes
- Vaginal dryness
- Mood changes
Rare complications may include blood clots and stroke.
Estrogen Receptor Downregulators
These treatments block and reduce estrogen receptors on cancer cells, limiting their ability to respond to hormones.
Possible side effects include:
- Headaches
- Nausea
- Bone pain
- Injection-site discomfort
Surgery
Surgical treatment may include:
- Lumpectomy, which removes the tumor while preserving most of the breast
- Mastectomy, which removes the entire breast
In some cases, doctors may recommend removal of the ovaries to reduce estrogen production and lower the risk of recurrence.
Importance of Early Detection
Early diagnosis significantly improves treatment outcomes. Regular breast screening can help identify cancer before symptoms develop.
Many health organizations recommend:
- Annual or regular mammograms beginning in midlife
- Earlier screening for people at higher risk
- Prompt medical evaluation of any unusual breast changes
Outlook
ER-positive breast cancer generally has a favorable outlook, particularly when diagnosed early. These tumors often grow more slowly than hormone receptor-negative cancers and respond well to hormone therapy.
Survival rates are highest when cancer is detected before it spreads beyond the breast. Even after successful treatment, long-term follow-up remains important because hormone receptor-positive cancers can sometimes return years later.
Key Takeaway
ER-positive breast cancer is a hormone-driven form of breast cancer that uses estrogen to grow. Advances in hormone therapy have significantly improved outcomes, making early diagnosis and targeted treatment critical for long-term survival and quality of life. Regular screening and awareness of breast changes remain essential tools in detecting the disease at its earliest and most treatable stages.
